ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 12,000
-30 (-0.25%)
At close: May 14, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 245.99 billion as of May 15, 2026. Its market cap has increased by 290.45% in one year.
Market Cap
245.99B
Enterprise Value
208.70B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
12,000.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 245.99B, a decrease of -56.17%. That is a compound annual growth rate of -16.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 245.99B | 23.08% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 328.72B |
| curacle co.,ltd. | 322.76B |
| Y-Biologics | 320.26B |
| TiumBio | 299.37B |
| NIBEC | 258.62B |
| Genome & Company | 250.88B |
| Bio Solution | 247.72B |
| ABION | 193.27B |